• LAST PRICE
    9.3000
  • TODAY'S CHANGE (%)
    Trending Down-0.0700 (-0.7471%)
  • Bid / Lots
    9.2800/ 6
  • Ask / Lots
    9.3000/ 6
  • Open / Previous Close
    9.3300 / 9.3700
  • Day Range
    Low 9.2000
    High 9.6200
  • 52 Week Range
    Low 7.1200
    High 13.0900
  • Volume
    499,667
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 9.37
TimeVolumeVIR
09:32 ET143049.2
09:33 ET37759.31
09:35 ET29369.25
09:37 ET5009.265
09:39 ET133509.35
09:42 ET7009.37
09:44 ET39669.3571
09:46 ET16179.3534
09:48 ET15919.36
09:50 ET22999.3543
09:51 ET8199.39
09:53 ET17349.38
09:55 ET16959.4
10:00 ET71589.46
10:02 ET29609.445
10:04 ET76629.56
10:06 ET8009.56
10:08 ET8009.55
10:09 ET25649.52
10:11 ET11039.515
10:13 ET32719.51
10:15 ET19489.485
10:18 ET4369.475
10:20 ET12779.42
10:22 ET43419.42
10:24 ET62969.41
10:26 ET1009.41
10:27 ET20049.43
10:29 ET11279.4201
10:31 ET25819.42
10:33 ET8909.43
10:36 ET23609.4
10:38 ET11079.39
10:40 ET75389.39
10:42 ET20969.375
10:44 ET20619.42
10:45 ET12029.44
10:47 ET10389.43
10:49 ET26009.42
10:51 ET30189.47
10:54 ET31359.41
10:56 ET6009.41
10:58 ET67369.43
11:00 ET8009.42
11:02 ET2009.43
11:03 ET32899.41
11:05 ET20449.425
11:07 ET66349.46
11:09 ET41829.46
11:12 ET15819.45
11:14 ET96699.49
11:16 ET1009.49
11:18 ET5009.5
11:20 ET14649.5
11:21 ET6029.5093
11:23 ET147139.55
11:25 ET317949.565
11:27 ET10409.5631
11:30 ET55459.62
11:32 ET404889.56
11:34 ET64489.57
11:36 ET24489.58
11:38 ET11109.59
11:39 ET6329.58
11:41 ET6009.6
11:43 ET71899.57
11:45 ET10979.59
11:48 ET5009.585
11:50 ET5499.585
11:52 ET14429.6
11:54 ET6009.605
11:56 ET26389.595
11:57 ET30579.5687
11:59 ET29519.57
12:01 ET49629.53
12:03 ET45009.53
12:06 ET26009.53
12:08 ET46359.5
12:10 ET31829.5
12:12 ET27999.475
12:14 ET38079.47
12:15 ET33009.47
12:17 ET17449.49
12:19 ET25009.46
12:21 ET28529.465
12:24 ET7009.47
12:26 ET12989.475
12:28 ET8009.48
12:30 ET19979.49
12:32 ET26059.49
12:33 ET9059.48
12:35 ET12009.475
12:37 ET8009.48
12:39 ET15919.48
12:42 ET15709.5
12:44 ET17009.485
12:46 ET30659.465
12:48 ET2009.47
12:50 ET16009.46
12:51 ET2009.47
12:53 ET23919.46
12:55 ET5009.47
12:57 ET15009.46
01:00 ET17569.47
01:02 ET7009.48
01:04 ET6009.47
01:06 ET49009.48
01:08 ET14359.45
01:11 ET2659.44
01:13 ET11039.39
01:15 ET25009.39
01:18 ET18149.38
01:20 ET53019.38
01:22 ET6009.36
01:24 ET9779.36
01:26 ET3009.355
01:27 ET5599.34
01:29 ET9599.345
01:31 ET14199.335
01:33 ET1899.32
01:36 ET8239.3
01:38 ET8009.28
01:40 ET3009.26
01:42 ET17329.28
01:44 ET9889.27
01:45 ET16189.3
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesVIR
Vir Biotechnology Inc
1.3B
-2.4x
---
United StatesIMTX
Immatics NV
1.3B
-10.2x
---
United StatesGYRE
Gyre Therapeutics Inc
1.4B
-16.9x
---
United StatesZYME
Zymeworks Inc
1.0B
-9.8x
---
United StatesRCUS
Arcus Biosciences Inc
1.4B
-4.9x
---
United StatesARDX
Ardelyx Inc
1.4B
-18.6x
---
As of 2024-11-05

Company Information

Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.

Contact Information

Headquarters
1800 OWENS STREET, SUITE 900SAN FRANCISCO, CA, United States 94158
Phone
415-906-4324
Fax
302-636-5454

Executives

Independent Chairman of the Board
Vicki Sato
Chief Executive Officer, Director
Marianne De Backer
Chief Financial Officer, Executive Vice President
Jason O'byrne
Executive Vice President, Chief Technology Officer
Ann Hanly
Executive Vice President, Chief Scientific Officer
Jennifer Towne

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.3B
Revenue (TTM)
$78.6M
Shares Outstanding
136.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.47
EPS
$-3.92
Book Value
$11.80
P/E Ratio
-2.4x
Price/Sales (TTM)
16.3
Price/Cash Flow (TTM)
---
Operating Margin
-774.67%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.